Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Sep 11, 2018 | Director | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Jun 15, 2018 | Principal Accounting Officer | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 5,723 | |
| Jun 15, 2018 | Principal Accounting Officer | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Dec 02, 2016 | Ten Percent Owner | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 13,223,947 | |
| Jun 13, 2016 | Ten Percent Owner | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 12,890,146 | |
| Jun 13, 2016 | Ten Percent Owner | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| May 30, 2014 | Ten Percent Owner | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 8,339,444 | |
| Dec 03, 2013 | Sr Vice President Discovery | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | 1,399,799 | |
| Dec 03, 2013 | Vice President Clinical Ops | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- | |
| Dec 03, 2013 | Vice President Clinical Ops | Initial Statement of Beneficial Ownership of Securities | Form 3 | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.